Pa. Judge Rules Against Provigil Pay-For-Delay Class Action Suit

Drug Industry Daily
A Pennsylvania district court refused to certify a group of corporate and institutional drug purchasers as plaintiffs in a class-action antitrust suit against several drugmakers — saying the approximately two-dozen organizations in the class was relatively small and did not meet legal class-action requirements.

To View This Article:


Subscribe To Drug Industry Daily